Skip to main content
. Author manuscript; available in PMC: 2011 May 9.
Published in final edited form as: J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):607–614. doi: 10.1097/QAI.0b013e3181648e16

TABLE 2.

IRs of Hypercholesterolemia by Selected Characteristics (N = 2122)

Characteristic Number Events Person-Years IR per 100 Person-Years (95% CI)
Overall rate 2122 277 8058.7 3.4 (3.0 to 3.9)
Baseline age (y)
    <6 480 76 1792.6 4.2 (3.3 to 5.3)
    6 to 9 693 102 2746.6 3.7 (3.0 to 4.5)
    10 to 12 535 65 2048.5 3.2 (2.5 to 4.0)
    ≥13 414 34 1471.0 2.3 (1.6 to 3.2)
Baseline viral load*
    ≤400 767 119 2903.0 4.1 (3.4 to 4.9)
    401 to 5000 503 61 1924.3 3.2 (2.4 to 4.1)
    5001 to 50,000 515 57 2022.3 2.8 (2.1 to 3.6)
    >50,000 272 34 940.2 3.6 (2.5 to 5.0)
PI use at baseline
    No 680 49 2657.8 1.8 (1.4 to 2.4)
    Yes, nonboosted 1027 174 3957.4 4.4 (3.8 to 5.1)
    Yes, boosted 415 54 1443.5 3.7 (2.8 to 4.9)
NNRTIs at baseline
    No 1404 180 5275.6 3.4 (2.9 to 3.9)
    Yes 718 97 2783.1 3.5 (2.8 to 4.2)
NRTIs at baseline
    None 93 6 323.5 1.8 (0.7 to 4.0)
    1 343 64 1299.6 4.9 (3.8 to 6.3)
    ≥2 1686 207 6435.6 3.2 (2.8 to 3.7)
Baseline HAART use
    HAART with PI 1412 218 5307.2 4.1 (3.6 to 4.7)
    HAART without PI 250 13 966.5 1.3 (0.7 to 2.3)
    ART without HAART 378 42 1505.0 2.8 (2.0 to 3.8)
    No ART 82 4 280.0 1.4 (0.4 to 3.7)
Time-dependent HAART use
    HAART with PI 1662 248 5182.9 4.8 (4.2 to 5.4)
    HAART without PI 459 7 949.5 0.7 (0.3 to 1.5)
    ART without HAART 640 19 1330.8 1.4 (0.9 to 2.2)
    No ART 594 3 595.5 0.5 (0.1 to 1.5)
    Blinded 1 0 0.008 0.0 (0.0 to 0.005)
*

Sixty-five children were missing a baseline viral load.

Numbers do not add up to 2122, because children can contribute time to more than 1 exposure group during follow-up.

One-sided, 97.5% CI.